help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parke, A.
Right arrow Articles by Lazarus, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parke, A.
Right arrow Articles by Lazarus, N. R.

American Journal of Pathology, Vol 130, 173-178, Copyright © 1988 by American Society for Investigative Pathology

REGULAR ARTICLES

Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea

A Parke, P Bhattacherjee, RM Palmer and NR Lazarus
Department of Mediator Pharmacology, Wellcome Research Laboratories, Kent, United Kingdom.

A model of angiogenesis in the rabbit cornea, with reproducible onset and duration of responses, was developed by using CuSO4 as the angiogenic stimulus. The vascularization of the cornea was quantified by means of an image analyzer. In addition, the effects of antiinflammatory compounds, dexamethasone and flurbiprofen, on the angiogenic response to CuSO4 were examined. Elvax pellets containing 10- 75 micrograms of CuSO4 implanted in the corneal stroma dose-dependently induced neovascularization, which persisted for more than 64 days at the highest dose. Manual measurements of blood vessel lengths and image analysis measurements of blood vessel areas were comparable during the growth phase of vascularization, but only the image analysis measurements detected a subsequent regression phase. Therefore, the length method of measurement is only useful during the growth phase, whereas the image analysis method is useful during both the growth and regression phases of vascularization. Dexamethasone (50 micrograms, applied topically, three times a day) and flurbiprofen (100 micrograms, applied topically, three times a day) suppressed the inflammation produced by corneal implants containing 75 micrograms CuSO4. However, each drug only inhibited vascular growth by 50% during the 14 days of treatment. Although CuSO4 is not an endogenous angiogenic factor, the model presented in this report may be useful in quantitative evaluation of anti-angiogenic agents.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
N. Saita, N. Fujiwara, I. Yano, K. Soejima, and K. Kobayashi
Trehalose 6,6'-Dimycolate (Cord Factor) of Mycobacterium tuberculosis Induces Corneal Angiogenesis in Rats
Infect. Immun., October 1, 2000; 68(10): 5991 - 5997.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. K. Sen, S. Khanna, M. Venojarvi, P. Trikha, E. C. Ellison, T. K. Hunt, and S. Roy
Copper-induced vascular endothelial growth factor expression and wound healing
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1821 - H1827.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society for Investigative Pathology.